Henrik Loft - Concepedia

Author

Henrik Loft

Lundbeck (Denmark)

Also Known As

H Loft, H. Loft, Henrik Loft, Loft H

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Lundbeck (Denmark)University Health Network University of Toronto University of Siena Imperial College London

About

Henrik Loft is an author at Lundbeck (Denmark) specializing in medicine, pharmacotherapy, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Social Sciences	8	8	815
3	Pharmacology	8	8	1K
4	Neuroscience	5	5	430
5	Neurology	2	2	221

Henrik Loft

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease Gordon Wilcock, Clive Ballard, James A. Cooper, The Journal of Clinical Psychiatry	2008	247
Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care Ulla Lepola, Henrik Loft, Elin Heldbo Reines International Clinical Psychopharmacology Psychotropic MedicationPsychopharmacologyMg/day CitalopramPharmacotherapyMental Health	2003	225
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis Serge Gauthier, Henrik Loft, Jeffrey L. Cummings International Journal of Geriatric Psychiatry	2007	219
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder Enric Álvarez, Víctor Pérez, Marianne Dragheim, The International Journal of Neuropsychopharmacology	2011	218
Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care Ulla Lepola, Henrik Loft, Elin Heldbo Reines International Clinical Psychopharmacology	2003	183
Oral clodronate in breast cancer patients with bone metastases: a randomized study Bent Bruun Kristensen, Bent Ejlertsen, M. Groenvold, Journal of Internal Medicine	1999	176
Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day Jean‐Philippe Boulenger, Henrik Loft, Christina Kurre Olsen International Clinical Psychopharmacology Madrs PointsPsychotropic MedicationPsychopharmacologyPharmacotherapyMental Health	2013	172
The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials R. W. McIntyre, John Harrison, Henrik Loft, The International Journal of Neuropsychopharmacology	2016	171
Escitalopram (S-Enantiomer of Citalopram): Clinical Efficacy and Onset of Action Predicted from a Rat Model Stuart Montgomery, Henrik Loft, Connie Sánchez, Pharmacology & Toxicology Psychotropic MedicationPsychopharmacologyMg/day CitalopramPharmacotherapyExperimental Pharmacology	2001	154
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD) David S. Baldwin, Henrik Loft, Marianne Dragheim European Neuropsychopharmacology Lu Aa21004PsychiatryMedicinePsychotropic MedicationPsychopharmacology	2011	151

Page 1